Fig. 5From: Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunityIncidence of Immune-checkpoint-hepatitis does not correlate with CMV serostatus. A Kaplan-Meier analysis of hepatitis events in patients grouped by IgG positivity against CMV. B Kaplan-Meier analysis of hepatitis events in young (< 55) and aged (≥ 55) patients with either negative or positive CMV IgG statusBack to article page